Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials

INTRODUCTION: The Kidney Cancer Research Network of Canada (KCRNC) collaborated to prepare this consensus statement about the use of target agents as adjuvant therapy in patients with non-metastatic renal cell carcinoma (nmRCC) after nephrectomy. We reviewed the published data and performed a meta-a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Can Urol Assoc J
Autores principales: Karakiewicz, Pierre I., Zaffuto, Emanuele, Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg A., Blais, Normand, Breau, Rodney H., Canil, Christina, Drachenberg, Darrel, Hotte, Sebastien J., Jeldres, Claudio, Jewett, Michael A.S., Kassouf, Wassim, Kollmannsberger, Christian, Lavallée, Luke T., Maloni, Ranjena, Patenaude, Francois, Pouliot, Frédéric, Reaume, M. Neil, Sabbagh, Robert, Shayegan, Bobby, So, Alan, Soulières, Denis, Tanguay, Simon, Wood, Lori, Bandini, Marco
Formato: Artigo
Lenguaje:Inglês
Publicado: Canadian Medical Association 2018
Materias:
Consensus Statement
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994982/
https://ncbi.nlm.nih.gov/pubmed/29877179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5187
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares